Rapid testing of C. diff patients

Triggered by antibiotic use, Clostridium difficile is the main cause of hospitalacquired diarrhoea. INVERNESS MEDICAL has introduced two new rapid tests.

TechLab TOX A/B Quik Chek and BioStar OIA CdTOX AB enable swift diagnosis and subsequent isolation of patients, reducing cross contamination in clinical areas. Delivering results in minutes, both tests qualitatively detect C. difficile Toxins A and B directly from human faecal specimens.

Clinical symptoms of C. difficile associated disease (CDAD) were once thought to be solely due to Toxin A. However, there is growing evidence that Toxin B may also play an important role in the pathogenesis of C. difficile. According to Inverness Medical’s VP International Business, David Walton, it is becoming mandatory in an increasing number of countries to use a test that detects both toxins.

A positive or negative result can be achieved in approximately 10 minutes.

Latest Issues

VyvaExperts25

Virtual
30th - 31st October 2025

AfPP Regional Conference – Edinburgh

John McIntyre Conference Centre, The University of Edinburgh
22nd November 2025

IDSc Annual Congress 2025

Hilton Birmingham Metropole
24th - 26th November 2025